[Federal Register Volume 62, Number 165 (Tuesday, August 26, 1997)]
[Notices]
[Page 45274]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-22569]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated April 12, 1997, and published in the Federal 
Register on May 12, 1997, (62 FR 25974), Roche Diagnostic Systems, 
Inc., 1080 U.S. Highway 202, Somerville, New Jersey 08876-3771, made 
application to the Drug Enforcement Administration to be registered as 
an importer of tetrahydrocannabinols (7370), a basic class of 
controlled substance listed in Schedule I.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Roche Diagnostic Systems, Inc. to 
import tetrahydrocannabinols is consistent with the public interest and 
with United States obligations under international treaties, 
conventions, or protocols in effect on May 1, 1971, at this time. 
Therefore, pursuant to Section 1008(a) of the Controlled Substances 
Import and Export Act and in accordance with Title 21, Code of Federal 
Regulations, Section 1301.34, the above firm is granted registration as 
an importer of the basic class of controlled substance listed above.

    Dated: July 21, 1997.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 97-22569 Filed 8-25-97; 8:45 am]
BILLING CODE 4410-09-M